National Trends in the Use of Cardiac Resynchronization Therapy with or Without Implantable Cardioverter-Defibrillator

Circulation

Volumn 133, Issue 3, 2016, Pages 273-281

  Lindvall, Charlotta ^a,b,c   Chatterjee, Neal A ^a   Chang, Yuchiao ^b,c   Chernack, Betty ^c   Jackson, Vicki A ^a,c   Singh, Jagmeet P ^a,c   Metlay, Joshua P ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b General Internal Medicine   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cardiac resynchronization therapy; cardiac resynchronization therapy devices; defibrillators, implantable; electric countershock; heart failure

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLACK PERSON; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ELIXHAUSER COMORBIDITY INDEX; FEMALE; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PACEMAKER IMPLANTATION; PRIORITY JOURNAL; RACE DIFFERENCE; ADOLESCENT; COHORT ANALYSIS; COMPARATIVE STUDY; EPIDEMIOLOGY; MIDDLE AGED; PROCEDURES; TRENDS; UNITED STATES; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 84955512192     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.018830     Document Type: Article

References (48)

1. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC, Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001 344 873 880. doi: 10.1056/NEJM200103223441202
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J, MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation Cardiac resynchronization in chronic heart failure. N Engl J Med 2002 346 1845 1853. doi: 10.1056/NEJMoa013168
3. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K, Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003 289 2685 2694. doi: 10.1001/jama.289.20.2685
4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 2140 2150. doi: 10.1056/NEJMoa032423
5. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 1539 1549. doi: 10.1056/NEJMoa050496
6. Chatterjee NA, Singh JP, Cardiac resynchronization therapy: past, present, and future. Heart Fail Clin 2015 11 287 303. doi: 10.1016/j.hfc.2014.12.007
7. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Kirchhof P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bänsch D, Baumgartner H, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Hasdai D, Hoes AW, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM, Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC, Wilson CM, ESC Committee for Practice Guidelines (CPG); Document Reviewers 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013 34 2281 2329. doi: 10.1093/eurheartj/eht150
8. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2013 127 e283 e352. doi: 10.1161/CIR.0b013e318276ce9b
9. Lam SK, Owen A, Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-Analysis of randomised controlled trials. BMJ 2007 335 925. doi: 10.1136/bmj.39343.511389.BE
10. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML, MADIT-II Investigators Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008 51 288 296. doi: 10.1016/j.jacc.2007.08.058
11. Tung R, Zimetbaum P, Josephson ME, A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008 52 1111 1121. doi: 10.1016/j.jacc.2008.05.058
12. Pun PH, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Hess PL, Inoue LY, Sanders GD, Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-Analysis of patient-level data from 3 randomized trials. Am J Kidney Dis 2014 64 32 39. doi: 10.1053/j.ajkd.2013.12.009
13. Passman R, Goldberger JJ, Predicting the future: risk stratification for sudden cardiac death in patients with left ventricular dysfunction. Circulation 2012 125 3031 3037. doi: 10.1161/CIRCULATIONAHA.111.023879
14. Overview of the National (Nationwide) Inpatient Sample (NIS). Rockville, MD Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed August 1, 2015
15. Elixhauser A, Steiner C, Harris DR, Coffey RM, Comorbidity measures for use with administrative data. Med Care 1998 36 8 27
16. Kheirbek RE, Alemi F, Fletcher R, Heart failure prognosis: comorbidities matter. J Palliat Med 2015 18 447 452. doi: 10.1089/jpm.2014.0365
17. Yurkovich M, Avina-Zubieta JA, Thomas J, Gorenchtein M, Lacaille D, A systematic review identifies valid comorbidity indices derived from administrative health data. J Clin Epidemiol 2015 68 3 14. doi: 10.1016/j.jclinepi.2014.09.010
18. Bilchick KC, Stukenborg GJ, Kamath S, Cheng A, Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol 2012 60 1647 1655. doi: 10.1016/j.jacc.2012.07.028
19. van Rees JB, Borleffs CJ, van Welsenes GH, van der Velde ET, Bax JJ, van Erven L, Putter H, van der Bom JG, Schalij MJ, Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score. Heart 2012 98 872 877. doi: 10.1136/heartjnl-2011-300632
20. Steinberg BA, Al-Khatib SM, Edwards R, Han J, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LY, Sanders GD, Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. J AM COLL CARDIOL. Heart Fail 2014 2 623 629. doi: 10.1016/j.jchf.2014.06.007
21. Kelli HM, Merchant FM, Mengistu A, Casey M, Hoskins M, El-Chami MF, Intermediate-Term mortality and incidence of ICD therapy in octogenarians after cardiac resynchronization therapy. J Geriatr Cardiol 2014 11 180 184. doi: 10.11909/j.issn.1671-5411.2014.03.014
22. Killu AM, Wu JH, Friedman PA, Shen WK, Webster TL, Brooke KL, Hodge DO, Wiste HJ, Cha YM, Outcomes of cardiac resynchronization therapy in the elderly. Pacing Clin Electrophysiol 2013 36 664 672. doi: 10.1111/pace.12048
23. Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, Defaye P, Jacob S, Piot O, Deharo JC, Perier MC, Mulak G, Hermida JS, Milliez P, Gras D, Cesari O, Hidden-Lucet F, Anselme F, Chevalier P, Maury P, Sadoul N, Bordachar P, Cazeau S, Chauvin M, Empana JP, Jouven X, Daubert JC, Le Heuzey JY, Causes-of-death analysis of patients with cardiac resynchronization therapy: An analysis of the certitude cohort study. Eur Heart J 2015 36 2767 2776. doi:10.1093/eurheartj/ehv474
24. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J, Scientific Committee; National Coordinators The European cardiac resynchronization therapy survey. Eur Heart J 2009 30 2450 2460. doi: 10.1093/eurheartj/ehp359
25. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008 117 e350 e408. doi: 10.1161/CIRCUALTIONAHA.108.189742
26. Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S, Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation 2008 117 1918 1926. doi: 10.1161/CIRCULATIONAHA.107.742155
27. Al-Khatib SM, Hellkamp AS, Hernandez AF, Fonarow GC, Thomas KL, Al-Khalidi HR, Heidenreich PA, Hammill S, Yancy C, Peterson ED, Get With the Guidelines Steering Committee and Hospitals Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation 2012 125 1094 1101. doi: 10.1161/CIRCULATIONAHA.111.066605
28. Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E, MADIT-CRT Executive Committee Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol 2012 59 2366 2373. doi: 10.1016/j.jacc.2012.01.065
29. Chatterjee NA, Roka A, Lubitz SA, Gold MR, Daubert C, Linde C, Steffel J, Singh JP, Mela T, Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-Analysis and systematic review. Eur Heart J 2015 36 2780 2789. doi:10.1093/eurheartj/ehv413
30. Daubert JC, Donal E, Linde C, A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy. Heart Fail Rev 2012 17 767 775. doi: 10.1007/s10741-011-9277-8
31. Bogale N, Priori S, Cleland JG, Brugada J, Linde C, Auricchio A, van Veldhuisen DJ, Limbourg T, Gitt A, Gras D, Stellbrink C, Gasparini M, Metra M, Derumeaux G, Gadler F, Buga L, Dickstein K, Scientific Committee, National Coordinators, and Investigators The European CRT Survey: 1 year (9-15 months) follow-up results. Eur J Heart Fail 2012 14 61 73. doi: 10.1093/eurjhf/hfr158
32. Bogale N, Priori S, Gitt A, Alings M, Linde C, Dickstein K, Scientific Committee, National coordinators, and investigators The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume. Europace 2011 13 1445 1453. doi: 10.1093/europace/eur173
33. Matlock DD, Peterson PN, Heidenreich PA, Lucas FL, Malenka DJ, Wang Y, Curtis JP, Kutner JS, Fisher ES, Masoudi FA, Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes 2011 4 114 121. doi: 10.1161/CIRCOUTCOMES.110.958264
34. Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, Masoudi FA, Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med 2012 172 634 641; discussion 641. doi: 10.1001/archinternmed.2012.394
35. Ajijola OA, Macklin EA, Moore SA, McCarty D, Bischoff KE, Heist EK, Picard M, Ruskin JN, Dec GW, Singh JP, Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-Term clinical outcome. Europace 2010 12 1745 1749. doi: 10.1093/europace/euq319
36. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K, Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007 115 2474 2480. doi: 10.1161/CIRCULATIONAHA.106.663807
37. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH, Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008 359 1009 1017. doi: 10.1056/NEJMoa071098
38. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG, The long-Term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007 28 42 51. doi: 10.1093/eurheartj/ehl382
39. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015 131 e29 322. doi: 10.1161/CIR.0000000000000152
40. Costea A, Rardon DP, Padanilam BJ, Fogel RI, Prystowsky EN, Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol 2008 19 266 269. doi: 10.1111/j.1540-8167.2007.01047.x
41. Al-Khatib SM, Hellkamp AS, Fonarow GC, Mark DB, Curtis LH, Hernandez AF, Anstrom KJ, Peterson ED, Sanders GD, Al-Khalidi HR, Hammill BG, Heidenreich PA, Hammill SC, Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. JAMA 2014 311 2209 2215. doi: 10.1001/jama.2014.5310
42. Kramer DB, Brock DW, Tedrow UB, Informed consent in cardiac resynchronization therapy: what should be said? Circ Cardiovasc Qual Outcomes 2011 4 573 577. doi: 10.1161/CIRCOUTCOMES.111.961680
43. Kobza R, Erne P, End-of-life decisions in ICD patients with malignant tumors. Pacing Clin Electrophysiol 2007 30 845 849. doi: 10.1111/j.1540-8159.2007.00771.x
44. Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M, Pe E, Bradley EH, Morrison RS, "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008 23 suppl 1) 7 12. doi: 10.1007/s11606-007-0239-8
45. Dunbar SB, Dougherty CM, Sears SF, Carroll DL, Goldstein NE, Mark DB, McDaniel G, Pressler SJ, Schron E, Wang P, Zeigler VL, American Heart Association Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Council on Cardiovascular Disease in the Young Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation 2012 126 2146 2172. doi: 10.1161/CIR.0b013e31825d59fd
46. Kinch Westerdahl A, Sjöblom J, Mattiasson AC, Rosenqvist M, Frykman V, Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life. Circulation 2014 129 422 429. doi: 10.1161/CIRCULATIONAHA.113.002648
47. Diamond GA, Kaul S, Cost, effectiveness, and cost-effectiveness. Circ Cardiovasc Qual Outcomes 2009 2 49 54. doi: 10.1161/CIRCOUTCOMES.108.793406
48. Quan H, Parsons GA, Ghali WA, Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 2002 40 675 685. doi: 10.1097/01.MLR.0000020927.46398.5D.